UTERINE NEOPLASMS
Clinical trials for UTERINE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UTERINE NEOPLASMS trials appear
Sign up with your email to follow new studies for UTERINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a combination of two drugs, tucatinib and trastuzumab, in people with advanced solid tumors that have HER2 alterations (too much or a different type of HER2 protein). The tumors have spread or cannot be removed by surgery. The main goal is to see if the treatment…
Matched conditions: UTERINE NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
New pill targets Cancer's 'Engine' in first human trial
Disease control OngoingThis is a first-in-human study to test the safety and find the right dose of an experimental pill called ATV-1601. It is for adults with advanced solid tumors, including certain breast, gynecologic, and prostate cancers, that have a specific genetic change called an AKT1 E17K mut…
Matched conditions: UTERINE NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Apr 13, 2026 20:17 UTC